Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2025 ,inter alia, to consider and approve 1. To consider ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals has notified the stock exchange that its Board of Directors will meet on Tuesday, August 5, 2025, at its registered office in Laxmi Nagar, East Delhi. The main agenda items are: (1) to consider and approve the unaudited financial results for Q1 FY26 (quarter ended June 30, 2025), (2) to change the Corporate Office of the company, and (3) to appoint three new directors — Mr. Ravi Thakor as Additional Non-Executive Non-Independent Director, and Mr. Yogeshkumar Prajapati and Mrs. Bhumika Pradhan as Additional Non-Executive Independent Directors. The signed intimation was filed by Managing Director Chintan Didawala Ganpat on July 31, 2025.
This is a routine pre-meeting notice, so there is no immediate price action. Investors should watch the August 5 outcome closely — the Q1 results will be the main trigger for any stock movement, while the three new director appointments expand the board ahead of the results.